Polaris Capital Management LLC Sells 4,600 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Polaris Capital Management LLC trimmed its UnitedHealth stake by 9.3% in Q4, selling 4,600 shares and leaving 44,712 shares valued at about $14.76 million.
• UnitedHealth reported a Q1 EPS beat ($7.23 vs. $6.76) and raised FY 2026 guidance, driving bullish flows, analyst upgrades and a short-term share rebound (opened at $355.05; market cap ≈ $322.5B).

Polaris Capital Management LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 44,712 shares of the healthcare conglomerate's stock after selling 4,600 shares during the period. Polaris Capital Management LLC's holdings in UnitedHealth Group were worth $14,760,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Beacon Financial Strategies CORP purchased a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. Foster Dykema Cabot & Partners LLC lifted its position in shares of UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 34 shares during the period. 1248 Management LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $29,000. Holos Integrated Wealth LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $29,000. Finally, Hurley Capital LLC increased its stake in shares of UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock worth $31,000 after acquiring an additional 40 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance raise: UNH reported a quarterly EPS beat and raised FY guidance, which analysts say has driven renewed momentum and a sharp short‑term share rebound. This is the primary driver behind today’s lift. A Look At UnitedHealth Group (UNH) Valuation As Q1 2026 Beat And Guidance Hike Drive Fresh Momentum
• Positive Sentiment: Prior authorization modernization: UnitedHealthcare said it will standardize a majority of electronic prior‑authorization submissions (70%+ by year‑end), reducing provider friction and potentially lowering administrative costs. This supports margin improvement expectations. UnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements
• Positive Sentiment: Large call‑option activity: Reported heavy buying of UNH call options signals bullish positioning from traders anticipating further upside after the earnings beat. That can amplify near‑term upward pressure on the stock. Investors Purchase Large Volume of UnitedHealth Group Call Options
• Positive Sentiment: High‑profile bullish media/analyst commentary: Jim Cramer and several outlets/analysts have highlighted UNH as a buy after the Q1 print, which is helping retail and momentum flows. Jim Cramer Says UNH at $354 Is a Steal — Here’s Why the Math Backs Him Up
• Positive Sentiment: Analyst upgrades / favorable coverage: Argus and other outlets have upgraded or upgraded coverage tone recently, adding credibility to the recovery story. Argus Research upgrades UnitedHealth Group (UNH)
• Neutral Sentiment: Valuation debate: Coverage discusses UNH’s P/E and valuation after the rebound; some view the stock as a value play now, while others caution the 1‑year TSR still lags. Valuation is driving contrasting investor views, sustaining volatility. UnitedHealth: Recovery Is Progressing, But Upside May Be Limited Near Term
• Negative Sentiment: Optum Health execution risk / limited near‑term upside: Independent analysis notes that while medical margins improved, Optum Health margins remain challenged and some recovery gains may be non‑structural—this could limit upside if operational recovery stalls. UnitedHealth: Recovery Is Progressing, But Upside May Be Limited Near Term
• Negative Sentiment: Governance proposal: A shareholder proposal seeking an independent board chair is drawing attention; the board opposes it. Governance disputes can create noise and potentially weigh on sentiment if shareholder activism grows. Independent Chair Proposal Tests Governance And Valuation Views At UnitedHealth Group
• Positive Sentiment: Rural health initiative: UNH launched a broad rural health program and prior‑authorization reductions for rural providers, strengthening growth/PR narrative in underserved markets. UnitedHealth Group Incorporated (UNH) Launches Broad Rural Health Initiative to Strengthen Underserved Communities
• Negative Sentiment: Mixed analyst notes: A recent price‑target adjustment (TD Cowen raise to $337 but maintained Hold) implies limited near‑term upside from some sell‑side desks—this can temper aggressive buy calls. TD Cowen raises price target to $337 (Hold)

UnitedHealth Group Stock Performance

UNH opened at $355.05 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market cap of $322.46 billion, a price-to-earnings ratio of 26.82, a PEG ratio of 1.53 and a beta of 0.40. The company's 50 day moving average is $293.40 and its 200 day moving average is $317.33. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $424.12.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm's revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm posted $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group's payout ratio is currently 66.77%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on UNH shares. Piper Sandler reiterated an "overweight" rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Royal Bank Of Canada increased their price target on shares of UnitedHealth Group from $361.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday. Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $405.00 to $411.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 7th. UBS Group reduced their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a research note on Wednesday, January 28th. Finally, Robert W. Baird raised their price objective on shares of UnitedHealth Group from $278.00 to $287.00 and gave the company an "underperform" rating in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $377.64.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.